Concepedia

F. H. Dexeus

FH

Statistics

Publications

11

Citations

1.5K

H-Index

11

Active since

1985

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Spanish Oncology Genitourinary Group

F. H. Dexeus is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and chemotherapy.

Publications per year

1985–1992

11

Publications

11

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.

C. Logothetis, F. H. Dexeus, Laura Finn et al. · Journal of Clinical Oncology · 1990 · 616 citations

, , +15

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

C. Logothetis, Douglas E. Johnson, Clayton Chong et al. · Journal of Clinical Oncology · 1988 · 164 citations

, , +17

Chemotherapy of extragonadal germ cell tumors.

C. Logothetis, M. L. Samuels, Debra E. Selig et al. · Journal of Clinical Oncology · 1985 · 126 citations

, , +17

Escalated Therapy for Refractory Urothelial Tumors: Methotrexate- Vinblastine-Doxorubicin- Cisplatin Plus Unglycosylated Recombinant Human Granulocyte-macrophage Colony-Stimulating Factor

Christopher J. Logothetis, F. H. Dexeus, Avishay Sella et al. · JNCI Journal of the National Cancer Institute · 1990 · 114 citations

, , +16

Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases.

James A. Neidhart, Stewart A. Anderson, James Harris et al. · Journal of Clinical Oncology · 1991 · 105 citations

, , +16

1–5 of 11